Cargando…

The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients

Objective: We aimed to investigate the potential role of ERBB signaling pathway–related genes in kidney renal clear cell carcinoma (KIRC) and establish a new predictive risk model using various bioinformatics methods. Methods: We downloaded the KIRC dataset and clinicopathological information from T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zicheng, Li, Jiayi, Zhang, Peizhi, Zhao, Leizuo, Huang, Bingyin, Xu, Yingkun, Wu, Guangzhen, Xia, Qinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314565/ https://www.ncbi.nlm.nih.gov/pubmed/35903358 http://dx.doi.org/10.3389/fgene.2022.862210

Ejemplares similares

Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis
por: Zhang, Peizhi, et al.
Publicado: (2023)

High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma
por: Qiu, Jiechuan, et al.
Publicado: (2023)

ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/β-Catenin Signaling Pathway
por: Zhang, Peizhi, et al.
Publicado: (2022)

Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma
por: Li, Xiunan, et al.
Publicado: (2022)

A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)

Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma
por: Qiu, Jiechuan, et al.
Publicado: (2023)

Analysis of genomes and transcriptomes of clear cell renal cell carcinomas identifies mutations and gene expression changes in the TGF-beta pathway
por: Che, Xiangyu, et al.
Publicado: (2022)

Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration
por: Wu, Guangzhen, et al.
Publicado: (2020)

A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
por: Xu, Yingkun, et al.
Publicado: (2020)

Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
por: Xu, Yingkun, et al.
Publicado: (2020)

Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma
por: Sun, Yonghao, et al.
Publicado: (2022)

Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma
por: Li, Jianyi, et al.
Publicado: (2020)

A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Qi, Xiaochen, et al.
Publicado: (2021)

Establishment of a prognostic ferroptosis- and immune-related long noncoding RNAs profile in kidney renal clear cell carcinoma
por: Han, Zhijun, et al.
Publicado: (2022)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
por: Gan, Kai, et al.
Publicado: (2022)

Genomic and Transcriptome Analysis to Identify the Role of the mTOR Pathway in Kidney Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
por: Che, Xiangyu, et al.
Publicado: (2021)

Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma
por: Sun, Ming, et al.
Publicado: (2022)

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
por: Wu, Guangzhen, et al.
Publicado: (2019)

Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2020)

A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)

A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2020)

Comparison of the Fatty Acid Metabolism Pathway in Pan-Renal Cell Carcinoma: Evidence from Bioinformatics
por: Wu, Ping, et al.
Publicado: (2021)

Angiogenesis Pathway in Kidney Renal Clear Cell Carcinoma and Its Prognostic Value for Cancer Risk Prediction
por: Che, Xiangyu, et al.
Publicado: (2021)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Xu, Shengxian, et al.
Publicado: (2022)

TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro
por: Xu, Yingkun, et al.
Publicado: (2020)

C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma
por: Yao, Wentao, et al.
Publicado: (2023)

Using Genomic and Transcriptome Analyses to Identify the Role of the Oxidative Stress Pathway in Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
por: Che, Xiangyu, et al.
Publicado: (2021)

AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma
por: Chen, Chen, et al.
Publicado: (2022)

The mechanism of liver X receptor regulates the balance of glycoFAsynthesis and cholesterol synthesis in clear cell renal cell carcinoma
por: Wang, Qifei, et al.
Publicado: (2023)

An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma
por: Yu, Qingxin, et al.
Publicado: (2022)

Construction and verification of a novel prognostic risk model for kidney renal clear cell carcinoma based on immunity-related genes
por: Liu, Yufeng, et al.
Publicado: (2023)

A novel endothelial-related prognostic index by integrating single-cell and bulk RNA sequencing data for patients with kidney renal clear cell carcinoma
por: Li, Deng-Xiong, et al.
Publicado: (2023)

Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target
por: Wu, Guangzhen, et al.
Publicado: (2021)

Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma
por: Ding, Junping, et al.
Publicado: (2022)

Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N(6)-Methyladenosine RNA Methylation Regulators
por: Zhang, Yan, et al.
Publicado: (2021)

Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma
por: Hong, Peng, et al.
Publicado: (2022)

Role of NF-κB pathway in kidney renal clear cell carcinoma and its potential therapeutic implications
por: Sun, Jiaao, et al.
Publicado: (2023)

Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration
por: Yao, Yimin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r3mdchkof06npt7fumpic5rjob